Effect of tetramethylpyrazine on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro
- PMID: 17364738
- DOI: 10.1080/02713680601088787
Effect of tetramethylpyrazine on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro
Abstract
Purpose: To evaluate the effect of tetramethylpyrazine (TMP) on laser-induced experimental choroidal neovascularization (CNV) in rat model in vivo and on endothelial cell proliferation in vitro.
Methods: Male Brown Norway rats were anesthetized to receive Nd:YAG laser to break the Bruch membrane. TMP was given once daily through intraperitoneal injection after laser treatment for 4 weeks. The development of CNV was determined by angiography performed on week 2 and week 4 using sodium fluorescein (FA) or fluorescein isothiocyanate-dextran (FD70-FA). Human umbilical vein endothelial cells (HUVECs) were tested with proliferation assay with TMP at different concentrations.
Results: According to the angiograms of FA, intensity of fluorescein leakage from the photocoagulated lesions decreased significantly after TMP treatment. The number of rats with less leaky points (<or= 75%) increased significantly in the TMP 40 mg/kg group (p < 0.05). The angiograms of FD70-FA showed diminished lesion size in the TMP-treated group. Four weeks after laser, the size of the CNV lesion was 2.69 +/- 0.24 mm2 in the control group, 2.00 +/- 0.14 mm2 in the TMP 20 mg/kg group, and 1.77 +/- 0.10 mm2 (p < 0.05) in the TMP 40 mg/kg group, respectively. TMP also interfered with endothelial cell proliferation significantly. The reduction of the endothelial cells was 53.7% (p < 0.05), 35.8% (p < 0.05), and 22.9% (p < 0.01), respectively, in the 300 micro g/ml, 100 micro g/ml, and 30 micro g/ml TMP-treated groups.
Conclusions: TMP inhibited the development of CNV in the rat model and interfered with vascular endothelial cell proliferation in vitro. TMP may be useful in the treatment of CNV.
Similar articles
-
Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro.J Ocul Pharmacol Ther. 2006 Feb;22(1):19-25. doi: 10.1089/jop.2006.22.19. J Ocul Pharmacol Ther. 2006. PMID: 16503771
-
Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2664-72. Invest Ophthalmol Vis Sci. 2001. PMID: 11581214
-
Apigenin inhibits laser-induced choroidal neovascularization and regulates endothelial cell function.J Ocul Pharmacol Ther. 2006 Dec;22(6):425-30. doi: 10.1089/jop.2006.22.425. J Ocul Pharmacol Ther. 2006. PMID: 17238808
-
Animal Models of Choroidal Neovascularization: A Systematic Review.Invest Ophthalmol Vis Sci. 2022 Aug 2;63(9):11. doi: 10.1167/iovs.63.9.11. Invest Ophthalmol Vis Sci. 2022. PMID: 35943733 Free PMC article.
-
The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.PLoS One. 2022 May 2;17(5):e0267968. doi: 10.1371/journal.pone.0267968. eCollection 2022. PLoS One. 2022. PMID: 35500001 Free PMC article.
Cited by
-
A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms.Front Pharmacol. 2025 Jan 23;16:1513406. doi: 10.3389/fphar.2025.1513406. eCollection 2025. Front Pharmacol. 2025. PMID: 39917620 Free PMC article. Review.
-
Effect of Tetramethylpyrazine on RPE degeneration, choroidal blood flow and oxidative stress of RPE cells.Int J Ophthalmol. 2010;3(3):205-10. doi: 10.3980/j.issn.2222-3959.2010.03.06. Epub 2010 Sep 18. Int J Ophthalmol. 2010. PMID: 22553555 Free PMC article.
-
TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2157-69. doi: 10.1167/iovs.11-9315. Invest Ophthalmol Vis Sci. 2012. PMID: 22410554 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical